Publications

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Author(s): Conti DV,  Wang K,  Sheng X,  Bensen JT,  Hazelett DJ,  Cook MB,  Ingles SA,  Kittles RA,  Strom SS,  Rybicki BA,  Nemesure B,  Isaacs WB,  Stanford JL,  Zheng W,  Sanderson M,  John EM,  Park JY,  Xu J,  Stevens VL,  Berndt SI,  Huff CD,  Wang Z,  Yeboah ED,  Tettey Y,  Biritwum RB,  Adjei AA,  Tay E,  Truelove A,  Niwa S,  Sellers TA,  Yamoah K,  Murphy AB,  Crawford DC,  Gapstur SM,  Bush WS,  Aldrich MC,  Cussenot O,  Petrovics G,  Cullen J,  Neslund-Dudas C,  Stern MC,  Jarai ZK,  Govindasami K,  Chokkalingam AP,  Hsing AW,  Goodman PJ,  Hoffmann T,  Drake BF,  Hu JJ,  Clark PE,  Van Den Eeden SK,  Blanchet P,  Fowke JH,  Casey G,  Hennis AJM,  Han Y,  Lubwama A,  Thompson IM Jr,  Leach R,  Easton DF,  Schumacher F,  Van den Berg DJ,  Gundell SM,  Stram A,  Wan P,  Xia L,  Pooler LC,  Mohler JL,  Fontham ETH,  Smith GJ,  Taylor JA,  Srivastava S,  Eeles RA,  Carpten J,  Kibel AS,  Multigner L,  Parent ME,  Menegaux F,  Cancel-Tassin G,  Klein EA,  Brureau L,  Stram DO,  Watya S,  Chanock SJ,  Witte JS,  Blot WJ,  Henderson BE,  Haiman CA,  PRACTICAL/ELLIPSE Consortium

Journal: J Natl Cancer Inst

Date: 2017 Aug 1

Major Program(s) or Research Group(s): PLCO

PubMed ID: 29117387

PMC ID: PMC5448553

Abstract: Prostate cancer incidence is 1.6-fold higher in African Americans than in other populations. The risk factors that drive this disparity are unknown and potentially consist of social, environmental, and genetic influences. To investigate the genetic basis of prostate cancer in men of African ancestry, we performed a genome-wide association meta-analysis using two-sided statistical tests in 10 202 case subjects and 10 810 control subjects. We identified novel signals on chromosomes 13q34 and 22q12, with the risk-associated alleles found only in men of African ancestry (13q34: rs75823044, risk allele frequency = 2.2%, odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.37 to 1.76, P = 6.10 × 10-12; 22q12.1: rs78554043, risk allele frequency = 1.5%, OR = 1.62, 95% CI = 1.39 to 1.89, P = 7.50 × 10-10). At 13q34, the signal is located 5' of the gene IRS2 and 3' of a long noncoding RNA, while at 22q12 the candidate functional allele is a missense variant in the CHEK2 gene. These findings provide further support for the role of ancestry-specific germline variation in contributing to population differences in prostate cancer risk.